Video Shorts

Biotech Security: A New National Defense Priority
0:56
Biotech Security: A New National Defense Priority
2 days ago
by
Mike Hollan(+1 more)
Exec on Execs
1:29
Exec on Execs: China's Rise in Biotech Investment
4 days ago
by
Mike Hollan
Market Movers Rx
1:13
Market Movers Rx: Iqvia Leads Gainers
7 days ago
by
Nicholas Jacobus
Execs on Exec
1:53
Execs on Exec: GLP-1 Coverage Gaps, China's Supply Chain, and the Clinical Trial Competitiveness Problem
11 days ago
by
Mike Hollan
Richard Graham
1:03
Why U.S. Biotech Regulation is Slow
11 days ago
by
Mike Hollan(+1 more)
Market. Movers Rx
1:19
Market Movers Rx: AbbVie Leads Gainers
14 days ago
by
Nicholas Jacobus
Susan Thomas
0:50
Why Your GLP-1 Strategy Is Failing
16 days ago
by
Mike Hollan(+1 more)
Gerren McHam VP API Innovation center
0:46
Why U.S. Manufacturing is Losing Its Competitive Edge
21 days ago
by
Nicholas Jacobus(+1 more)
Why We Need Better Drugs, Not Just More Drugs
0:54
Why We Need Better Drugs, Not Just More Drugs
24 days ago
by
Mike Hollan(+1 more)
market watch RX
1:21
Market Watch RX: Gilead Joins Top Gainers
a month ago
by
Nicholas Jacobus
The Key to AI Scale-Up
0:27
The Key to AI Scale-Up
a month ago
by
Michael Christel(+1 more)
Market Watch RX
1:14
Market Watch Rx: Zoetis Shares Slid
a month ago
by
Nicholas Jacobus
The Billions Invested in Domestic Manufacturing
0:51
The Billions Invested in Domestic Manufacturing
a month ago
by
Mike Hollan(+1 more)
Lisa Bollinger
0:56
Big FDA & EMA Changes for Rare Disease Therapies
a month ago
by
Mike Hollan(+1 more)
The Challenges Bringing Pharma and Biotech Manufacturing Back to the U.S.
0:53
The Challenges Bringing Pharma and Biotech Manufacturing Back to the U.S.
a month ago
by
Mike Hollan(+1 more)
Brian Hilberdink, president of U.S. Human Pharma, Boehringer Ingelheim,
0:36
Why Employers Are Blocking Obesity Drugs?
2 months ago
by
Nicholas Jacobus(+1 more)
Silvia Taylor
1:04
How Novavax’s Protein-Based Vaccine Technology Works
2 months ago
by
Mike Hollan(+1 more)
Market Watch Rx
1:18
Market Watch Rx: Medtronic Leads Gainers
2 months ago
by
Nicholas Jacobus
Tackling Duplicate Discounts
0:47
Tackling Duplicate Discounts
2 months ago
by
Michael Christel(+1 more)
Why Basket Trials Are Changing Rare Disease Research
0:59
Why Basket Trials Are Changing Rare Disease Research
2 months ago
by
Mike Hollan(+1 more)
Market Watch Rx
1:06
Market Watch Rx: Cigna Joins Top Gainers
2 months ago
by
Nicholas Jacobus
Will Shrank
1:13
Solving the Healthcare Cost Crisis Through Collective Action
2 months ago
by
Mike Hollan(+1 more)
Market Watch Rx
1:06
Market Watch Rx: Editas Medicine Leads Gainers
2 months ago
by
Nicholas Jacobus
The First Amendment's Impact on DTC Prescription Drug Ads
0:46
The First Amendment's Impact on DTC Prescription Drug Ads
2 months ago
by
Mike Hollan(+1 more)
Harpreet Singh, MD, chief medical officer at Precision for Medicine and former FDA Oncology Division Director,
0:38
Improving FDA & Biopharma's Relationship
2 months ago
by
Nicholas Jacobus(+1 more)
Big Pharma’s Next Big Shift: Rare Diseases vs. Mass Markets
0:59
Big Pharma’s Next Big Shift: Rare Diseases vs. Mass Markets
2 months ago
by
Mike Hollan(+1 more)
Market Watch RxThis week on Market Watch Rx, we break down the biggest biopharma stock movers, from gains at Zoetis and Stryker to declines for Editas and Regeneron.
1:15
Market Watch Rx: Baxter International Leads Gainers
3 months ago
by
Nicholas Jacobus
FDA's Shift: Why Predictability Now Matters More Than Speed
0:43
FDA's Shift: Why Predictability Now Matters More Than Speed
3 months ago
by
Mike Hollan(+1 more)
Richard Graham
0:45
Using Data to Come to the Right Conclusions
3 months ago
by
Mike Hollan(+1 more)
Market Watch Rx
1:12
Market Watch Rx: Humana Leads Top Gainers
3 months ago
by
Nicholas Jacobus